Soligenix (NASDAQ: SNGX) is advancing a differentiated approach to orphan drug development, emphasizing a de-risked model focused on patient safety and capital efficiency, as highlighted in a recent citybiz feature. The company’s lead candidate, HyBryte(TM), targets cutaneous T-cell lymphoma using visible light activation rather than traditional chemotherapy or UV-based therapies, with clinical data indicating faster response times and a favorable safety profile, while…
ParaZero Technologies (NASDAQ: PRZO) announced it has entered into a definitive agreement for a registered direct offering with a single institutional investor expected to generate approximately $4 million in gross proceeds through the sale of 5,333,333 ordinary shares (or pre-funded warrants) at $0.75 per share. The company said proceeds will be used for general corporate purposes and…
Soligenix (NASDAQ: SNGX) announced that new supportive trial data for HyBryte(TM) in the treatment of cutaneous T-cell lymphoma will be presented at the United States Cutaneous Lymphoma Consortium Workshop on March 26, 2026, ahead of the American Academy of Dermatology Annual Meeting. The presentations will highlight positive results from a long-term treatment study and a comparative analysis versus Valchlor(R),…
DitGold (CRYPTO: DITAU) is now accessible through the Coinbase app decentralized exchange (DEX) functionality, enabling users to trade the token directly using assets such as USDC or ETH within the platform. The availability follows Coinbase Global Inc. (NASDAQ: COIN) continued expansion of its DEX capabilities, which provide access to a broad range of Ethereum- and Base-based tokens without requiring…
Co-Diagnostics (NASDAQ: CODX) announced that its Indian joint venture, CoSara Diagnostics Pvt. Ltd., has signed an agreement to expand its commercial and distribution territory across South Asia to include Bangladesh, Pakistan, Nepal and Sri Lanka, significantly increasing its addressable market to an estimated $13.0 billion. The expansion supports planned commercialization of the CoSara PCR Pro(R) point-of-care platform and SARAGENE(R) product line, subject to regulatory…
Perpetuals.com (NASDAQ: PDC) announced that CEO Patrick Gruhn will present and host a live question-and-answer session at the Emerging Growth Conference on April 1, 2026, at 12:35 p.m. ET, where he is expected to discuss the company AI-powered financial services platform and engage with investors. To view the full press release, visit https://ibn.fm/EZgBf About Perpetuals.com Ltd. Perpetuals.com…
Pelican Acquisition (NASDAQ: PELI) announced that shareholders approved its proposed business combination with Pelican Holdco Inc., Greenland Exploration Limited and March GL Company at an extraordinary general meeting held March 19, 2026, with closing of the transaction expected on or about March 24, 2026. The deal is intended to form a publicly traded energy company…
Black Hawk Acquisition (Nasdaq: BKHA, BKHAU, BKHAR) announced that its proposed de-SPAC acquisition target, Vesicor Therapeutics Inc., has appointed Michael Tolentino, M.D., as chief executive officer effective March 17, 2026, succeeding founder Luo Feng, Ph.D., who will transition to chief scientific officer as the company advances its p53-based cancer therapeutic platform and prepares for IND-enabling studies and a…
ParaZero Technologies (NASDAQ: PRZO) announced the signing of a strategic cooperation agreement with India-based BonV Aero to market its portfolio of counter-UAS solutions, led by the DefendAir system, a mobile, net-based interception platform designed for rapid deployment against hostile drones, while also enabling future configurations and integrations. The companies have already conducted a live demonstration…
Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company focused on rare diseases, announced that a comprehensive summary of clinical trials evaluating HyBryte(TM) (synthetic hypericin) for cutaneous T-cell lymphoma has been published in the peer-reviewed journal Expert Opinion on Investigational Drugs, highlighting the therapy’s safety profile, non-mutagenic mechanism and demonstrated efficacy across studies, while supporting its potential as a first-line treatment…
Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company focused on rare diseases, was featured in the latest BioMedWire Podcast episode where CEO Christopher Schaber discussed the upcoming interim analysis of the Phase 3 FLASH2 study evaluating HyBryte(TM) for cutaneous T-cell lymphoma, noting strong blinded aggregate response rates above initial assumptions and outlining potential outcomes including early study completion or continued enrollment, while…
Forward Industries (NASDAQ: FWDI), the leading Solana treasury company, announced it has entered into a privately negotiated agreement to repurchase 6,164,324 shares for $27.4 million, reducing shares outstanding and increasing SOL-per-share to 0.0662 following the transaction, which is being financed through a $40 million digital currency loan agreement with Galaxy Digital secured by treasury assets…
Datavault AI (NASDAQ: DVLT), a provider of data monetization, credentialing, digital engagement and real-world asset tokenization technologies, announced it has signed a definitive agreement to acquire NYIAX Inc., adding NYIAX’s intellectual property portfolio and blockchain-powered trading platform to support Datavault AI’s planned rollout of specialized exchanges, including its Information Data Exchange(R), while combining AI-driven valuation,…
Nutriband (NASDAQ: NTRB) announced that the Costa Rica Ministry of Health has approved its line of kinesiology tapes for import and sale, with exclusive distribution partner Innomedica CCB overseeing and financing the regulatory process. The company plans to ramp up marketing efforts in partnership with Innomedica, targeting both its kinesiology tape products and mosquito repellent patch line following the…
NRx Pharmaceuticals (NASDAQ: NRXP) announced it received a letter from the FDA’s Bioequivalence Program stating no bioequivalence deficiencies were identified at this time in its Abbreviated New Drug Application, with a preliminary determination ahead of anticipated approval in Summer 2026. The company highlighted its preservative-free ketamine formulation, which excludes benzethonium chloride, as a potential advancement in safety and stability, while continuing to pursue…
Safe Pro Group (NASDAQ: SPAI) announced it has completed participation in the U.S. Army Transforming in Contact (TiC) 2.0 Autonomous Breach event, where its patented AI tools were deployed in real-world operational environments by soldiers and command personnel during a two-week exercise at Fort Hood, Texas. The company’s SPOTD platform and NODE system were used to identify threats,…
Datavault AI (NASDAQ: DVLT) announced it will report financial results for the fourth quarter and full year 2025 prior to market open on March 19, 2026, followed by a conference call and live webcast at 8:30 a.m. ET the same day. CEO Nathaniel Bradley and CFO Brett Moyer will host the presentation, with dial-in access…
Innovation Beverage Group (NASDAQ: IBG) announced the closing of a registered public offering that generated approximately $6 million in gross proceeds before fees and expenses. The offering consisted of 3,428,569 common units or pre-funded units, each including one ordinary share or pre-funded warrant along with Series A and Series B warrants to purchase additional ordinary shares at an exercise price of $1.75 per share.…
Wearable Devices (NASDAQ: WLDS) announced a significant expansion of its AI expert advisory board to support the advancement of its ai6 Labs initiative, which is focused on neural AI innovation powered by non-invasive electromyography technology and the company’s Mudra platform. The company said the expanded advisory leadership includes Leor Stern as Senior AI Advisor for strategic growth alongside existing…